Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study

被引:46
|
作者
Nakayama, Masaaki [1 ,2 ]
Sato, Toshinobu [3 ]
Miyazaki, Mariko
Matsushima, Masato [4 ]
Sato, Hiroshi [5 ]
Taguma, Yoshio [3 ]
Ito, Sadayoshi
机构
[1] Tohoku Univ, Grad Sch Med, Ctr Adv Integrated Renal Sci, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Fukushima Med Univ, Sch Med, Fukushima, Japan
[3] Sendai Shakaihoken Hosp, Kidney Ctr, Sendai, Miyagi, Japan
[4] Jikei Univ, Sch Med, Dept Clin Res, Tokyo, Japan
[5] Tohoku Univ, Grad Sch Pharmacol, Dept Clin Pharmacol, Sendai, Miyagi 9808574, Japan
关键词
cardiovascular disease; chronic kidney disease; hypertensive nephropathy; GENERAL JAPANESE POPULATION; GLOMERULAR-FILTRATION-RATE; MECHANISMS; DYSLIPIDEMIA; PATHOGENESIS; PROTEINURIA; CHILDREN; OUTCOMES; STRESS; STROKE;
D O I
10.1038/hr.2011.96
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
To examine the clinical significance of hypertensive nephropathy (HN) among non-diabetic chronic kidney disease (CKD) patients. The study comprised 2692 CKD patients recruited from 11 outpatient nephrology clinics; these included 1306 patients with primary renal disease (PRD), 458 patients with HN, 283 patients with diabetic nephropathy (DN) and 645 patients with other nephropathies (ONs). All patients fulfilled the criteria of CKD, with a persistent low estimated glomerular filtration rate (eGFR) <60 ml min(-1) per 1.73 m(2) or proteinuria as determined by a urine dipstick test. The risk factors for cardiovascular disease (CVD), such as ischemic heart disease, congestive heart failure and stroke; all-cause mortality; and progression to end-stage renal failure (dialysis induction) were analyzed using a Cox proportional hazards model in each group. During a mean follow-up period of 22.6 months from recruitment, 100 patients were lost to follow-up and 192 patients began chronic dialysis therapy. A total of 115 CVD events occurred (stroke in 37 cases), and 44 patients died. Regarding CVD events and death, there were significant differences in the hazard ratios (HRs) for the groups of patients with different underlying renal diseases as determined by both univariate and multivariate analysis adjusted for confounding factors including estimated glomerular filtration rate: PRD, 1.0 (reference); HN, 3.33 (95% confidence interval, 1.82-6.09); DN, 5.93 (2.80-12.52); and ON, 2.22 (1.22-4.05). However, there were no differences in the hazard ratio for dialysis induction for the groups of patients with different underlying renal diseases. HN is associated with an increased risk of CVD events and death among non-diabetic CKD patients, which highlights the clinical significance of HN. Hypertension Research (2011) 34, 1106-1110; doi:10.1038/hr.2011.96; published online 28 July 2011
引用
收藏
页码:1106 / 1110
页数:5
相关论文
共 50 条
  • [1] Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study
    Masaaki Nakayama
    Toshinobu Sato
    Mariko Miyazaki
    Masato Matsushima
    Hiroshi Sato
    Yoshio Taguma
    Sadayoshi Ito
    Hypertension Research, 2011, 34 : 1106 - 1110
  • [2] Different clinical outcomes for cardiovascular events and mortality in chronic kidney disease according to underlying renal disease: the Gonryo study
    Nakayama, Masaaki
    Sato, Toshinobu
    Sato, Hiroshi
    Yamaguchi, Yuji
    Obara, Katsuya
    Kurihara, Isao
    Sato, Kazuto
    Hotta, Osamu
    Seino, Jin
    Miyata, Masahiro
    Takeuchi, Kazuhisa
    Nakayama, Kenji
    Matsushima, Masato
    Otaka, Tetsuya
    Kinoshita, Yasumichi
    Taguma, Yoshio
    Ito, Sadayoshi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2010, 14 (04) : 333 - 339
  • [3] Effect of allopurinol on cardiovascular incidence among hypertensive nephropathy patients: the Gonryo study
    Terawaki, Hiroyuki
    Nakayama, Masaaki
    Miyazawa, Emiko
    Murata, Yaeko
    Nakayama, Keisuke
    Matsushima, Masato
    Miyazaki, Mariko
    Sato, Hiroshi
    Sato, Mitsuhiro
    Sato, Toshinobu
    Taguma, Yoshio
    Ito, Sadayoshi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (04) : 549 - 553
  • [4] Effect of allopurinol on cardiovascular incidence among hypertensive nephropathy patients: the Gonryo study
    Hiroyuki Terawaki
    Masaaki Nakayama
    Emiko Miyazawa
    Yaeko Murata
    Keisuke Nakayama
    Masato Matsushima
    Mariko Miyazaki
    Hiroshi Sato
    Mitsuhiro Sato
    Toshinobu Sato
    Yoshio Taguma
    Sadayoshi Ito
    Clinical and Experimental Nephrology, 2013, 17 : 549 - 553
  • [5] Different clinical outcomes for cardiovascular events and mortality in chronic kidney disease according to underlying renal disease: the Gonryo study
    Masaaki Nakayama
    Toshinobu Sato
    Hiroshi Sato
    Yuji Yamaguchi
    Katsuya Obara
    Isao Kurihara
    Kazuto Sato
    Osamu Hotta
    Jin Seino
    Masahiro Miyata
    Kazuhisa Takeuchi
    Kenji Nakayama
    Masato Matsushima
    Tetsuya Otaka
    Yasumichi Kinoshita
    Yoshio Taguma
    Sadayoshi Ito
    Clinical and Experimental Nephrology, 2010, 14 : 333 - 339
  • [6] Increased Circulating Visfatin Is Associated With Progression of Kidney Disease in Non-Diabetic Hypertensive Patients
    Hsu, Chien-Yi
    Huang, Po-Hsun
    Chen, Tz-Heng
    Chiang, Chia-Hung
    Leu, Hsin-Bang
    Huang, Chin-Chou
    Chen, Jaw-Wen
    Lin, Shing-Jong
    AMERICAN JOURNAL OF HYPERTENSION, 2016, 29 (04) : 528 - 536
  • [7] Estimated glucose disposal rate for predicting cardiovascular events and mortality in patients with non-diabetic chronic kidney disease: a prospective cohort study
    Peng, Juan
    Zhang, Yan
    Zhu, Yiqun
    Chen, Weilin
    Chen, Li
    Ma, Fangyu
    Yi, Bin
    Huang, Zhijun
    BMC MEDICINE, 2024, 22 (01):
  • [8] Increased cardiovascular risk in patients with chronic kidney disease
    Vondenhoff, Sonja
    Schunk, Stefan J.
    Noels, Heidi
    HERZ, 2024, : 95 - 104
  • [9] Triglycerides-glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease
    Quiroga, Borja
    Munoz Ramos, Patricia
    Sanchez Horrillo, Ana
    Ortiz, Alberto
    Manuel Valdivieso, Jose
    Carrero, Juan Jesus
    CLINICAL KIDNEY JOURNAL, 2022, 15 (09) : 1705 - 1712
  • [10] Beta-blockers are associated with increased risk of first cardiovascular events in non-diabetic hypertensive elderly patients
    Brouwers, Frederieke M.
    Courteau, Josiane
    Cohen, Alan A.
    Farand, Paul
    Cloutier, Lyne
    Asghari, Shabnam
    Vanasse, Alain
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (11) : 1139 - 1146